Cyteir Leadership 2018-03-08T12:00:32+00:00

Cyteir Leadership


Markus Renschler, MD
Markus Renschler, MDPresident and Chief Executive Officer
Kevin Mills, PhD
Kevin Mills, PhDFounder and Chief Scientific Officer
Darryl Patrick, PhD, DVM
Darryl Patrick, PhD, DVMHead of Preclinical Research and Development
 Ronald Goldstein, CPA
Ronald Goldstein, CPAChief Financial Officer
Joseph Vacca, PhD
Joseph Vacca, PhDHead of Chemistry

“It is with patients in the forefront of our minds that we work diligently to develop novel gain of function synthetic lethal therapies”

Melinda Anne Lynch Day, PhD – Principal Scientist, Cyteir Therapeutics, Inc.